27 Sep, 2022 Are governments prepared for another pandemic? By Dhara Reddy On Health Tech World, a recent YouGov survey shows that 49% of healthcare professionals in various countries agree that health systems...
21 Sep, 2022 mRNA Vaccines: a growing and complex IP landscape By Ellen Lambrix The September 2022 edition of the Vaccine Insights journal has been published and includes a commentary article by Robert Burrows and...
20 Sep, 2022 US authorities crack down on remote prescribing of controlled drugs. Could the same happen in the UK? By Jamie Hatzel According to a recent article from the Verge, the US' Drug Enforcement Administration has opened an investigation into Done Global Inc, a...
31 Jan, 2022 Five Life Sciences trends for 2022 By Claire Smith What trends do we expect to see in the Life Sciences sector for 2022? We’ve had a look into our crystal ball and picked out some of the...
30 Nov, 2021 mRNA COVID vaccines: Omicron variant tests platform adaptability and regulatory flexibility By Ellen Lambrix Over the last week, more new cases of the COVID-19 Omicron variant have been detected across the globe. While we don't yet know how...
23 Nov, 2021 Voluntary licensing on the rise as Medicines Patent Pool signs second deal for COVID-19 treatment By Ellen Lambrix It was announced last week (16 November 2021) that Pfizer has agreed a voluntary licence with the UN-backed Medicines Patent Pool for...
02 Nov, 2021 Potential future applications of mRNA technology By Hugo Kent-Egan The ground-breaking success of the mRNA vaccines against COVID-19 has radically changed how this technology is viewed and has...
02 Aug, 2021 Post pandemic recovery: Hospitality must accelerate digital transformation and adopt data-focussed approach By Freya Ollerearnshaw There has been a significant step-change in the adoption of online technologies in response to the pandemic. Digital transformation has...
22 Jul, 2021 COVID-19 and animal vaccines By Claire Smith Now sixteen months on from the start of the COVID-19 pandemic, the Government is looking to the future and putting measures in place to...
06 May, 2021 US backs waiver on patents for Covid-19 vaccines By Liz Cohen The US government has declared its support for a temporary suspension of intellectual property rights for Covid-19 vaccines. The waiver,...
11 Feb, 2021 EBA reference on oral proceedings by ViCo By Robert Burrows Due to the COVID pandemic the EPO has been conducting oral hearings by video-conference. Initially, this could only be done by agreement...
10 Feb, 2021 Vaccine safety: MHRA releases surveillance strategy By Bristows The rapid detection, characterisation and quantification of safety issues related to Covid-19 vaccines is essential to protecting public...